Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Nov;82(2):363–368. doi: 10.1111/j.1365-2249.1990.tb05454.x

Interpretation of blocking activity in maternal serum depends on the equation used for calculation of mixed lymphocyte culture results.

M I Park 1, S S Edwin 1, J R Scott 1, D W Branch 1
PMCID: PMC1535110  PMID: 2146996

Abstract

Immunosuppressive blocking factors in maternal serum are usually determined by inhibition of mixed lymphocyte cultures (MLC), but reports on the importance of these factors for successful pregnancy are conflicting. Here we measured serum blocking activity in men, non-pregnant nulliparous women, non-pregnant multiparous women, women with normal pregnancies, and in women who had had recurrent spontaneous abortions and were treated with leucocyte immunizations. Three different equations were used for calculation of blocking activity: blocking effect index (BEI); stimulation index (SI); and blocking index (BI). By all three methods of calculation, significantly lower levels of blocking activity were noted for men and women compared with pregnant women and multiparae. In the patients with a history of recurrent spontaneous abortions blocking activity as determined by BEI and BI increased into the positive range after treatment with infusions of third-party donor leucocytes in a statistically significant number of women (P less than 0.05). However, blocking activity as determined by BEI had a higher predictive value for successful pregnancy than did that determined by BI or SI. Our data suggest that the equation used for calculating BEI is superior to other methods for the determination of blocking activity when monitoring the response to leucocyte immunization in women with recurrent spontaneous abortion. However, these results also cast doubt on the importance of blocking antibodies in histories of recurrent abortion, since pregnancies occurred in the absence and spontaneous abortions occurred in the presence of blocking activity.

Full text

PDF
363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adinolfi M. Recurrent habitual abortion, HLA sharing and deliberate immunization with partner's cells: a controversial topic. Hum Reprod. 1986 Jan;1(1):45–48. doi: 10.1093/oxfordjournals.humrep.a136342. [DOI] [PubMed] [Google Scholar]
  2. Beer A. E., Quebbeman J. F., Ayers J. W., Haines R. F. Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol. 1981 Dec 15;141(8):987–999. doi: 10.1016/s0002-9378(16)32690-4. [DOI] [PubMed] [Google Scholar]
  3. Beer A. E., Semprini A. E., Zhu X. Y., Quebbeman J. F. Pregnancy outcome in human couples with recurrent spontaneous abortions: HLA antigen profiles; HLA antigen sharing; female serum MLR blocking factors; and paternal leukocyte immunization. Exp Clin Immunogenet. 1985;2(3):137–153. [PubMed] [Google Scholar]
  4. Branch D. W., Andres R., Digre K. B., Rote N. S., Scott J. R. The association of antiphospholipid antibodies with severe preeclampsia. Obstet Gynecol. 1989 Apr;73(4):541–545. [PubMed] [Google Scholar]
  5. Burlingham W. J. What is known about blocking factors in renal allograft recipients. Am J Reprod Immunol Microbiol. 1988 Jan;16(1):15–20. doi: 10.1111/j.1600-0897.1988.tb00171.x. [DOI] [PubMed] [Google Scholar]
  6. Caudle M. R., Rote N. S., Scott J. R., DeWitt C., Barney M. F. Histocompatibility in couples with recurrent spontaneous abortion and normal fertility. Fertil Steril. 1983 Jun;39(6):793–798. doi: 10.1016/s0015-0282(16)47119-0. [DOI] [PubMed] [Google Scholar]
  7. Daya S., Clark D. A., Devlin C., Jarrell J. Preliminary characterization of two types of suppressor cells in the human uterus. Fertil Steril. 1985 Dec;44(6):778–785. doi: 10.1016/s0015-0282(16)49037-0. [DOI] [PubMed] [Google Scholar]
  8. Fizet D., Bousquet J. Absence of a factor blocking a cellular cytotoxicity reaction in the serum of women with recurrent abortions. Br J Obstet Gynaecol. 1983 May;90(5):453–456. doi: 10.1111/j.1471-0528.1983.tb08943.x. [DOI] [PubMed] [Google Scholar]
  9. Gatenby P. A., Moore H., Cameron K., Doran T. J., Adelstein S. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: correlates with outcome. Am J Reprod Immunol. 1989 Jan;19(1):21–27. doi: 10.1111/j.1600-0897.1989.tb00543.x. [DOI] [PubMed] [Google Scholar]
  10. Hellström K. E., Hellström I., Brawn J. Abrogation of cellular immunity to antigenically foreign mouse embryonic cells by a serum factor. Nature. 1969 Nov 29;224(5222):914–915. doi: 10.1038/224914a0. [DOI] [PubMed] [Google Scholar]
  11. Hofmeyr G. J., Joffe M. I., Bezwoda W. R., van Iddekinge B. Immunologic investigation of recurrent pregnancy loss and consequences of immunization with husbands' leukocytes. Fertil Steril. 1987 Oct;48(4):681–684. doi: 10.1016/s0015-0282(16)59486-2. [DOI] [PubMed] [Google Scholar]
  12. Holland N. H., Holland P. Immunological maturation in an infant of an agammaglobulinaemic mother. Lancet. 1966 Nov 26;2(7474):1152–1155. doi: 10.1016/s0140-6736(66)90473-9. [DOI] [PubMed] [Google Scholar]
  13. Kilpatrick D. C. A case of materno-foetal histocompatibility--implications for leucocyte transfusion treatment for recurrent aborters. Scott Med J. 1984 Apr;29(2):110–112. doi: 10.1177/003693308402900210. [DOI] [PubMed] [Google Scholar]
  14. Kobayashi R. H., Hyman C. J., Stiehm E. R. Immunologic maturation in an infant born to a mother with agammaglobulinemia. Am J Dis Child. 1980 Oct;134(10):942–944. doi: 10.1001/archpedi.1980.02130220020006. [DOI] [PubMed] [Google Scholar]
  15. Labarrere C., Althabe O., Caletti E., Muscolo D. Deficiency of blocking factors in intrauterine growth retardation and its relationship with chronic villitis. Am J Reprod Immunol Microbiol. 1986 Jan;10(1):14–19. doi: 10.1111/j.1600-0897.1986.tb00003.x. [DOI] [PubMed] [Google Scholar]
  16. McIntyre J. A., Faulk W. P. Trophoblast antigens in normal and abnormal human pregnancy. Clin Obstet Gynecol. 1986 Dec;29(4):976–998. doi: 10.1097/00003081-198612000-00021. [DOI] [PubMed] [Google Scholar]
  17. Mittal K. K., Mickey M. R., Singal D. P., Terasaki P. I. Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation. 1968 Nov;6(8):913–927. doi: 10.1097/00007890-196811000-00006. [DOI] [PubMed] [Google Scholar]
  18. Mowbray J. F., Gibbings C., Liddell H., Reginald P. W., Underwood J. L., Beard R. W. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet. 1985 Apr 27;1(8435):941–943. doi: 10.1016/s0140-6736(85)91723-4. [DOI] [PubMed] [Google Scholar]
  19. Nicholas N. S., Panayi G. S. Immunosuppressive properties of pregnancy serum on the mixed lymphocyte reaction. Br J Obstet Gynaecol. 1986 Dec;93(12):1251–1255. doi: 10.1111/j.1471-0528.1986.tb07860.x. [DOI] [PubMed] [Google Scholar]
  20. Oksenberg J. R., Persitz E., Amar A., Brautbar C. Maternal-paternal histocompatibility: lack of association with habitual abortions. Fertil Steril. 1984 Sep;42(3):389–395. doi: 10.1016/s0015-0282(16)48078-7. [DOI] [PubMed] [Google Scholar]
  21. Oksenberg J. R., Persitz E., Amar A., Schenker J., Segal S., Nelken D., Brautbar C. Mixed lymphocyte reactivity nonresponsiveness in couples with multiple spontaneous abortions. Fertil Steril. 1983 Apr;39(4):525–529. [PubMed] [Google Scholar]
  22. Regan L., Braude P. R. Is antipaternal cytotoxic antibody a valid marker in the management of recurrent abortion? Lancet. 1987 Nov 28;2(8570):1280–1280. doi: 10.1016/s0140-6736(87)91896-4. [DOI] [PubMed] [Google Scholar]
  23. Rocklin R. E., Kitzmiller J. L., Carpenter C. B., Garovoy M. R., David J. R. Maternal-fetal relation. Absence of an immunologic blocking factor from the serum of women with chronic abortions. N Engl J Med. 1976 Nov 25;295(22):1209–1213. doi: 10.1056/NEJM197611252952201. [DOI] [PubMed] [Google Scholar]
  24. Rocklin R. E., Kitzmiller J. L., Garvoy M. R. Maternal-fetal relation. II. Further characterization of an immunologic blocking factor that develops during pregnancy. Clin Immunol Immunopathol. 1982 Mar;22(3):305–315. doi: 10.1016/0090-1229(82)90047-2. [DOI] [PubMed] [Google Scholar]
  25. Rodger J. C. Lack of a requirement for a maternal humoral immune response to establish or maintain successful allogeneic pregnancy. Transplantation. 1985 Oct;40(4):372–375. doi: 10.1097/00007890-198510000-00006. [DOI] [PubMed] [Google Scholar]
  26. Sargent I. L., Wilkins T., Redman C. W. Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet. 1988 Nov 12;2(8620):1099–1104. doi: 10.1016/s0140-6736(88)90522-3. [DOI] [PubMed] [Google Scholar]
  27. Scott J. R., Rote N. S., Branch D. W. Immunologic aspects of recurrent abortion and fetal death. Obstet Gynecol. 1987 Oct;70(4):645–656. [PubMed] [Google Scholar]
  28. Slapsys R. M., Clark D. A. Active suppression of host-vs-graft reaction in pregnant mice. IV. Local suppressor cells in decidua and uterine blood. J Reprod Immunol. 1982 Dec;4(6):355–364. doi: 10.1016/0165-0378(82)90010-9. [DOI] [PubMed] [Google Scholar]
  29. Smith J. B., Cowchock F. S. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome. J Reprod Immunol. 1988 Nov;14(2):99–113. doi: 10.1016/0165-0378(88)90062-9. [DOI] [PubMed] [Google Scholar]
  30. Stimson W. H., Strachan A. F., Shepherd A. Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women. Br J Obstet Gynaecol. 1979 Jan;86(1):41–45. doi: 10.1111/j.1471-0528.1979.tb10682.x. [DOI] [PubMed] [Google Scholar]
  31. Takakuwa K., Kanazawa K., Takeuchi S. Production of blocking antibodies by vaccination with husband's lymphocytes in unexplained recurrent aborters: the role in successful pregnancy. Am J Reprod Immunol Microbiol. 1986 Jan;10(1):1–9. doi: 10.1111/j.1600-0897.1986.tb00001.x. [DOI] [PubMed] [Google Scholar]
  32. Terasaki P. I., Bernoco D., Park M. S., Ozturk G., Iwaki Y. Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol. 1978 Feb;69(2):103–120. doi: 10.1093/ajcp/69.2.103. [DOI] [PubMed] [Google Scholar]
  33. Thomas M. L., Harger J. H., Wagener D. K., Rabin B. S., Gill T. J., 3rd HLA sharing and spontaneous abortion in humans. Am J Obstet Gynecol. 1985 Apr 15;151(8):1053–1058. doi: 10.1016/0002-9378(85)90379-5. [DOI] [PubMed] [Google Scholar]
  34. Unander A. M., Lindholm A. Transfusions of leukocyte-rich erythrocyte concentrates: a successful treatment in selected cases of habitual abortion. Am J Obstet Gynecol. 1986 Mar;154(3):516–520. doi: 10.1016/0002-9378(86)90593-4. [DOI] [PubMed] [Google Scholar]
  35. ZAK S. J., GOOD R. A. Immunochemical studies of human serum gamma globulins. J Clin Invest. 1959 Mar;38(3):579–586. doi: 10.1172/JCI103835. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES